SFM
AZN icon

Signet Financial Management’s AstraZeneca AZN Stock Holding History

Signet Financial Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69M Sell
13,656
-294
-2% -$56.7K 0.3% 107
2025
Q4 		$2.56M Buy
+13,950
New +$2.45M 0.29% 106
2022
Q1 		– Sell
-206
Closed -$24K – 343
2021
Q4 		$24K Buy
+206
New +$24.2K ﹤0.01% 793

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Signet Financial Management's AZN Position: Q1 2026 in Review

Signet Financial Management reduced its AstraZeneca (AZN) stake by 2.1% in Q1 2026, selling an estimated $56.7K and leaving 13,656 shares worth $2.69M. The position accounts for 0.3% of the portfolio, ranked #107.

Signet Financial Management first reported a position in AZN in Q4 2021 and has held it in 3 quarters since. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Signet Financial Management held 13,656 shares of AstraZeneca worth $2.69M as of Q1 2026.
  • Signet Financial Management sold 294 AstraZeneca shares in Q1 2026, an estimated $56.7K.
  • AstraZeneca made up 0.3% of Signet Financial Management's portfolio in Q1 2026, its #107 holding.
  • Signet Financial Management first reported a position in AstraZeneca in Q4 2021 and has held it in 3 quarters since.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.